178 related articles for article (PubMed ID: 22370955)
1. Understanding fragmentation of prostate cancer survivorship care: implications for cost and quality.
Skolarus TA; Zhang Y; Hollenbeck BK
Cancer; 2012 Jun; 118(11):2837-45. PubMed ID: 22370955
[TBL] [Abstract][Full Text] [Related]
2. The economic burden of prostate cancer survivorship care.
Skolarus TA; Zhang Y; Miller DC; Wei JT; Hollenbeck BK
J Urol; 2010 Aug; 184(2):532-8. PubMed ID: 20620413
[TBL] [Abstract][Full Text] [Related]
3. Caring for Alaska Native prostate cancer survivors in primary care: a survey of Alaska Tribal Health System providers.
Tilburt JC; Kelley S; DeCourtney CA; Humeniuk KM; Latini J; Kim SP
Int J Circumpolar Health; 2014; 73():23637. PubMed ID: 24596707
[TBL] [Abstract][Full Text] [Related]
4. Primary care perspectives on prostate cancer survivorship: implications for improving quality of care.
Skolarus TA; Holmes-Rovner M; Northouse LL; Fagerlin A; Garlinghouse C; Demers RY; Rovner DR; Darwish-Yassine M; Wei JT
Urol Oncol; 2013 Aug; 31(6):727-32. PubMed ID: 21775171
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.
Macleod LC; Yabes JG; Fam MM; Bandari J; Yu M; Maganty A; Furlan A; Filson CP; Davies BJ; Jacobs BL
Eur Urol Focus; 2020 Mar; 6(2):242-248. PubMed ID: 31031042
[TBL] [Abstract][Full Text] [Related]
6. Providing prostate cancer survivorship care in Japan: Implications from the USA care model.
Osawa T; Wittmann D; Jimbo M; Keller ET; Namiki S; Abe T; Shinohara N; Skolarus TA
Int J Urol; 2016 Nov; 23(11):906-915. PubMed ID: 27624609
[TBL] [Abstract][Full Text] [Related]
7. Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial.
Skolarus TA; Metreger T; Hwang S; Kim HM; Grubb RL; Gingrich JR; Hawley ST
Trials; 2017 Apr; 18(1):181. PubMed ID: 28420419
[TBL] [Abstract][Full Text] [Related]
8. Determinants of quality prostate cancer survivorship care across the primary and specialty care interface: Lessons from the Veterans Health Administration.
Radhakrishnan A; Henry J; Zhu K; Hawley ST; Hollenbeck BK; Hofer T; Wittmann DA; Sales AE; Skolarus TA
Cancer Med; 2019 May; 8(5):2686-2702. PubMed ID: 30950216
[TBL] [Abstract][Full Text] [Related]
9. Differences in ambulatory care fragmentation between cancer survivors and noncancer controls.
Pinheiro LC; Reshetnyak E; Safford MM; Nanus D; Kern LM
Cancer; 2020 Jul; 126(13):3094-3101. PubMed ID: 32286692
[TBL] [Abstract][Full Text] [Related]
10. Shifting focus to cancer survivorship in prostate cancer: challenges and opportunities.
Gilbert SM
Curr Opin Urol; 2008 May; 18(3):326-32. PubMed ID: 18382244
[TBL] [Abstract][Full Text] [Related]
11. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
Zanwar P; Lin YL; Kuo YF; Goodwin JS
BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
[TBL] [Abstract][Full Text] [Related]
12. The Risk of Catastrophic Healthcare Expenditures Among Prostate and Bladder Cancer Survivors in the United States.
Stone BV; Labban M; Filipas DK; Beatrici E; Lipsitz SR; Reis LO; Feldman AS; Kibel AS; Cole AP; Morgans AK; Trinh QD
Clin Genitourin Cancer; 2023 Dec; 21(6):617-625. PubMed ID: 37316413
[TBL] [Abstract][Full Text] [Related]
13. Quality of cancer survivorship care in the military health system (TRICARE).
Fox JP; Jeffery DD; Williams TV; Gross CP
Cancer J; 2013; 19(1):1-9. PubMed ID: 23337750
[TBL] [Abstract][Full Text] [Related]
14. Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels: Results from a Qualitative Analysis.
Shen MJ; Nelson CJ; Peters E; Slovin SF; Hall SJ; Hall M; Herrera PC; Leventhal EA; Leventhal H; Diefenbach MA
Med Decis Making; 2015 May; 35(4):477-86. PubMed ID: 25385751
[TBL] [Abstract][Full Text] [Related]
15. Survivorship: adult cancer survivors.
Ganz PA
Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
[TBL] [Abstract][Full Text] [Related]
16. Enhancing prostate cancer survivorship care through self-management.
Skolarus TA; Wittmann D; Hawley ST
Urol Oncol; 2017 Sep; 35(9):564-568. PubMed ID: 28619632
[TBL] [Abstract][Full Text] [Related]
17. Physician and facility drivers of spending variation in locoregional prostate cancer.
Rodin D; Chien AT; Ellimoottil C; Nguyen PL; Kakani P; Mossanen M; Rosenthal M; Landrum MB; Sinaiko AD
Cancer; 2020 Apr; 126(8):1622-1631. PubMed ID: 31977081
[TBL] [Abstract][Full Text] [Related]
18. Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients.
Sun M; Marchese M; Friedlander DF; Nguyen DD; Cole AP; Fletcher SA; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
Urol Oncol; 2021 Feb; 39(2):130.e17-130.e24. PubMed ID: 33309298
[TBL] [Abstract][Full Text] [Related]
19. Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group.
Narayan V; Harrison M; Cheng H; Kenfield S; Aggarwal R; Kwon D; McKay R; Hauger R; Hart N; Conzen S; Borno H; Jim H; Dicker A; Dorff T; Moslehi J; Mucci L; Parsons JK; Saad F; Soule H; Morgans A; Ryan CJ
Urol Oncol; 2020 Mar; 38(3):83-93. PubMed ID: 31734020
[TBL] [Abstract][Full Text] [Related]
20. Identifying patients' priorities for quality survivorship: conceptualizing a patient-centered approach to survivorship care.
Mead KH; Raskin S; Willis A; Arem H; Murtaza S; Charney L; Pratt-Chapman M
J Cancer Surviv; 2020 Dec; 14(6):939-958. PubMed ID: 32607715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
